Ciara Kennedy

Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study

Emmanuel Gonzalès, Winita Hardikar, Michael Stormon et al. · The Lancet · 2021 · 169 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Ocular changes in patients undergoing long-term desferrioxamine treatment.

G. B. Arden, B. Wonke, Ciara Kennedy et al. · British Journal of Ophthalmology · 1984 · 97 citations · Full text

Medicine, Ophthalmology, Pharmacology +6

A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis

Marlyn J. Mayo, Paul J. Pockros, David Jones et al. · Hepatology Communications · 2019 · 95 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Maralixibat for the treatment of PFIC: Long‐term, IBAT inhibition in an open‐label, Phase 2 study

Kathleen M. Loomes, Robert H. Squires, Déirdre Kelly et al. · Hepatology Communications · 2022 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

Renger G. Tiessen, Ciara Kennedy, Bradley T. Keller et al. · BMC Gastroenterology · 2018 · 50 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17